These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30115498)

  • 1. Corrigendum to "Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis" [Biomed. Pharmacother. 97 (330-338) 330-338].
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Nov; 107():1795. PubMed ID: 30115498
    [No Abstract]   [Full Text] [Related]  

  • 2. Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis.
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Jan; 97():330-338. PubMed ID: 29091882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo" [Biomed. Pharmacother. 97 (2018) 481-488].
    Zheng L; Yin L; Xu L; Qi Y; Li H; Youwei X; Han X; Liu K; Peng J
    Biomed Pharmacother; 2019 Dec; 120():109448. PubMed ID: 31615697
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor" [Biomed. Pharmacother. 90 (2017) 914-920].
    Zhang H; Yan X; Wang DG; Leng YF; Wan ZH; Liu YQ; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1569. PubMed ID: 29153378
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms" [Biomed. Pharmacother. 115 (2019) 108881].
    Wen J; Wang J; Li P; Wang R; Wang J; Zhou X; Zhang L; Li H; Wei S; Cai H; Zhao Y
    Biomed Pharmacother; 2019 Jul; 115():108936. PubMed ID: 31101386
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2/HO-1 signaling pathway" [Biomed. Pharmacother. 121 (2020) 109676].
    Jin W; Zhu X; Yao F; Xu X; Chen X; Luo Z; Zhao D; Li X; Leng X; Sun L
    Biomed Pharmacother; 2020 Feb; 122():109808. PubMed ID: 31902541
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation" [Biomed. Pharmacother. 109 (2018) 2278-2284].
    Zhang Y; Xiang Y; Wang X; Zhu L; Li H; Wang S; Pan X; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108548. PubMed ID: 30773235
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 May; 101():786. PubMed ID: 29525673
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2018 Feb; 98():925-926. PubMed ID: 29421862
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts" [Biomed. Pharmacother. 115 (2019) 108889].
    Weng J; Tu M; Wang P; Zhou X; Wang C; Wan X; Zhou Z; Wang L; Zheng X; Li J; Chen C; Wang Z; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109085. PubMed ID: 31178264
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling" [Biomed. Pharmacother. 116 (2019) 108749].
    Li Y; Zuo H; Wang H; Hu A
    Biomed Pharmacother; 2020 Mar; 123():109815. PubMed ID: 31932124
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Comparative study of therapeutic response to baclofen vs tolperisone in spasticity" [Biomed. Pharmacother. 87 (2017) 628-635].
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Aug; 92():1140. PubMed ID: 28623068
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "17β-Estradiol/extrogen receptor β alleviates apoptosis and enhances matrix biosynthesis of nucleus pulposus cells through regulating oxidative damage under a high glucose condition" [Biomed. Pharmacother. 207 (2018) 1004-1009].
    Yang D; Zhu D; Zhu S; Feng F; Gong C; Chen C; Chen L
    Biomed Pharmacother; 2019 Apr; 112():108739. PubMed ID: 30852062
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review" [Biomed. Pharmacother. 92 (2017) 681-689].
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Shams-Ul-Hassan S
    Biomed Pharmacother; 2018 May; 101():820. PubMed ID: 29525678
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124" [Biomed. Pharmacother. 126 (2020) 109786].
    Miao W; Yan Y; Bao TH; Jia WJ; Yang F; Wang Y; Zhu YH; Yin M; Han JH
    Biomed Pharmacother; 2020 Sep; 129():110597. PubMed ID: 32798084
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2018 Mar; 99():1033-1036. PubMed ID: 29398246
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" [Biomed. Pharmacother. 93(2017):444-450].
    Li D; Liu J; Wei D; Liu H; Xiao W; Song X; Fan Z; Ke C; Qiangguo Y; Qin W; Tang Y; Xiaoyong P
    Biomed Pharmacother; 2018 Aug; 104():854. PubMed ID: 29753602
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2020 Dec; 132():110828. PubMed ID: 33053510
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition" [Biomed. Pharmacother. 103 (2018) 1202-1211].
    Lee SA; Moon SM; Han SH; Hwang EJ; Park BR; Kim JS; Kim DK; Kim CS
    Biomed Pharmacother; 2020 Jul; 127():110190. PubMed ID: 32423657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.